| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $348.1M | — | +36.1% |
| R&D Expense | $48.2M | — | +34.5% |
| SG&A Expense | $212.6M | — | +37.5% |
| Operating Income | -$84.7M | — | -23.3% |
| Interest Expense | $14.3M | — | -20.3% |
| Pre-tax Income | -$122.9M | — | -9.4% |
| Income Tax | -$62K | — | +99.9% |
| Net Income | -$125.9M | — | -85.1% |
| EPS (Basic) | -$0.70 | — | -75.0% |
| EPS (Diluted) | -$0.71 | — | -77.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $521.2M | -13.8% | +243.8% |
| Accounts Receivable | $308.6M | -0.8% | +17.5% |
| Inventory | $51.8M | +0.2% | +2.7% |
| Current Assets | $1.05B | -9.7% | +83.6% |
| Total Assets | $2.14B | -6.1% | +38.4% |
| Current Liabilities | $318.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$73.3M | — | +30.6% |
| Capital Expenditures | $8.2M | — | +295.5% |
| Investing Cash Flow | -$10.1M | — | +97.3% |
| Financing Cash Flow | -$271K | — | -100.1% |
| Free Cash Flow | -$81.5M | — | +24.3% |
| -5.5% |
| Total Liabilities | $1.72B | -3.6% | +41.2% |
| Stockholders' Equity | $416.4M | -15.2% | +27.7% |